-
Viewpoint: India Must Keep Patent Laws for Manufacture of Cheap Generic Drugs
Recently, trade ministers from 10 Asean countries, India, China, Japan, Australia, New Zealand and South Korea gathered to negotiate a deal on the Regional Comprehensive Economic Partnership (RCEP) trade agreement. But, RCEP negotiations on intellectual property (IP) are at a standstill because India and the Asean countries are unwilling to trade away health by adopting IP provisions that go beyond what is required of them under international trade rules.
- Categories
- Health Care
- Region
- South Asia
- Tags
- public policy
-
Are Pharma Giants Living Up to Big Promises on Development?
he pharmaceutical industry plays a fundamental role in achieving international development targets. This was recognised in the millennium development goals (MDGs), which explicitly mention that providing access to affordable essential drugs in low- and middle-income countries has to be achieved “in cooperation with pharmaceutical companies”. Yet efforts to track progress towards the MDGs have focused mainly on government action rather than corporate contributions.
- Categories
- Health Care
-
NASA Langley Helps Drone Technology Get Its ‘Kitty Hawk Moment’
Tousands of patients at an annual outdoor free clinic in Wise County were treated to a unique sight recently when for the first time medical supplies flew in on an unmanned drone.
- Categories
- Health Care
-
Sanofi Preps for ‘Profitable’ Dengue Vaccine Rollout in 20 Countries
With more than $1.5 billion in development costs and 20 years of research on the line, Sanofi ($SNY) is getting revved up to launch its world-first dengue vaccine later this year. And if the company's predictions are correct, the shot will not only be a big deal for patients in the developing world--it'll be a highly profitable product to boot.
- Categories
- Health Care
-
Partnerships and Innovation to Defeat Malaria: An Interview With Dr. David Reddy
Dr David Reddy is CEO of Medicines for Malaria Venture (MMV), a product development partnership that works with both the public and private sectors to facilitate the discovery, development and delivery of new antimalarial drugs. Before his public lecture held at the Crawford School (presentation available here), Dr Reddy sat down with Camilla Burkot to talk about MMV’s role in tackling malaria. You can listen to the podcast here and read the full transcript here. For a summary of their discussion, read on.
- Categories
- Health Care
-
Breakthrough Global Agreement Sharply Lowers Price of Early Infant Diagnosis of HIV
Global partners in the Diagnostics Access Initiative have joined with Roche Diagnostics to announce a 35% reduction in the price for HIV early infant diagnostic technologies. The new access price is US$ 9.40 per test, including proprietary reagents and consumables associated with diagnosing HIV in very young children. Partners involved in the negotiation of this reduced access price include UNAIDS, the Clinton Health Access Initiative Inc., the United States President’s Emergency Plan for AIDS Relief (PEPFAR), the Global Fund to Fight AIDS, Tuberculosis and Malaria and UNITAID.
- Categories
- Health Care
-
Bridging Gap in the Health Care Sector: AfDB Offers Strategic Analysis on Financing Innovatively With the Private Sector
“The relevance of private sector role in delivering innovative health care to the poorest people, with the view to achieving global goal,” was underscored at a side event organized today in Addis-Ababa, Ethiopia by the Bill and Melinda Gates Foundation.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
‘Arogya Sakhi’ Tablets Are Revolutionising Indian Rural Healthcare
It is common knowledge that health care services in rural India are not easily accessible and health awareness among the people is poor. Swayam Shikshan Prayog (SSP), a learning and development organization has stepped in to improve the situation in rural Maharashtra through a programme called Arogya Sakhi reports The Better India.
- Categories
- Health Care
- Region
- South Asia
